(marketscreener.com) The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: ---------- 4D Pharma PLC - Leeds-based pharmaceutical firm - Gives update on signal finding study of MRx0518 in combination with anti-PD-1 therapy Keytruda on patients with solid tumours that have progressed on a...https://www.marketscreener.com/quote/stock/4D-PHARMA-PLC-56171591/news/TRADING-UPDATES-GCP-Infra-hails-NAV-rise-Jadestone-profits-from-oil-42892241/?utm_medium=RSS&utm_content=20230203
4D pharma is an England-based pharmaceutical company that develops and commercializes biotherapeutic products for the treatment of cancer, CNS and neurodegenerative diseases.